Von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome

Pediatric Research

Volumn 49, Issue 5, 2001, Pages 653-659

  Tsai, H M ^a   Chandler, W L ^a   Sarode, R ^a   Hoffman, R ^a   Jelacic, S ^a   Habeeb, R L ^a   Watkins, S L ^a   Wong, C S ^a   Williams, G D ^a   Tarr, P I ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; METALLOPROTEINASE; METHIONINE; TYROSINE; VON WILLEBRAND FACTOR;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ESCHERICHIA COLI; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHEAR STRESS; THROMBOTIC THROMBOCYTOPENIC PURPURA; THROMBUS;

EID: 0035035397     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200105000-00008     Document Type: Article

References (34)

1. Pathology of the hemolytic uremic syndrome
2. The hemolytic-uremic syndrome is a syndrome
3. The pathogenesis and treatment of hemolytic uremic syndrome
4. No common final pathogenetic pathway in haemolytic uraemic syndromes
5. Escherichia coli O157:H7 and the hemolytic uremic syndrome: Importance of early cultures in establishing the etiology
6. Hemolytic-uremic syndrome after shigellosis
7. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor
8. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma
9. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis
10. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion
11. Shear-dependent changes in the three dimensional structure of human von Willebrand factor
12. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
13. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome
14. Abnormal VIII: Von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome
15. Von Willebrand factor abnormalities in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome
16. Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome
17. Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome
18. The risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
19. DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages
20. Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2
21. Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987
22. The identification of platelets and platelet antigens in histological sections
23. Thrombotic thrombocytopenic purpura associated with clopidogrel
24. Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients
25. Immunohistochemistry of vascular lesions in thrombotic thrombocytopenic purpura with special reference to factor VIII antigen
26. The hemolytic uremic syndrome
27. Colitis in children with the hemolytic uremic syndrome
28. Gastrointestinal disease in the hemolytic-uremic syndrome
29. Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura
30. Characterization of the baboon responses to Shiga-like toxin: Descriptive study of a new primate model of toxic responses to Stx-1
31. Treatment of the childhood haemolytic uraemic syndrome with plasma
32. Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial